BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 32416433)

  • 1. Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic: A single-center experience.
    Rossi D
    Lung Cancer; 2020 Jul; 145():83-84. PubMed ID: 32416433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic.
    Chang HL; Wei PJ; Wu KL; Huang HL; Yang CJ
    Lung Cancer; 2020 Aug; 146():376-377. PubMed ID: 32576385
    [No Abstract]   [Full Text] [Related]  

  • 3. Covid-19 and lung cancer: A greater fatality rate?
    Rogado J; Pangua C; Serrano-Montero G; Obispo B; Marino AM; Pérez-Pérez M; López-Alfonso A; Gullón P; Lara MÁ
    Lung Cancer; 2020 Aug; 146():19-22. PubMed ID: 32505076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?
    Sereno M; Gutiérrez-Gutiérrez G; Sandoval C; Falagan S; Jimenez-Gordo AM; Merino M; López-Menchaca R; Martínez-Martin P; Roa S; Casado E
    Lung Cancer; 2020 Jul; 145():213-215. PubMed ID: 32389426
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
    Di Noia V; D'Aveni A; Squadroni M; Beretta GD; Ceresoli GL
    Lung Cancer; 2020 Jul; 145():208-210. PubMed ID: 32439211
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
    Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
    Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment and outcome of a pulmonary sarcomatoid carcinoma patient infected with SARS-CoV-2.
    Wang K; Liu Y; Hu T; Liu Y; Liu C
    Lung Cancer; 2020 Aug; 146():373-375. PubMed ID: 32563532
    [No Abstract]   [Full Text] [Related]  

  • 8. Two Sorts of Microthrombi in a Patient With Coronavirus Disease 2019 and Lung Cancer.
    Calabrese F; Fortarezza F; Giraudo C; Pezzuto F; Faccioli E; Rea F; Pittarello D; Correale C; Navalesi P
    J Thorac Oncol; 2020 Nov; 15(11):1782-1785. PubMed ID: 32866652
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib for COVID-19: A case report.
    Morales-Ortega A; Bernal-Bello D; Llarena-Barroso C; Frutos-Pérez B; Duarte-Millán MÁ; García de Viedma-García V; Farfán-Sedano AI; Canalejo-Castrillero E; Ruiz-Giardín JM; Ruiz-Ruiz J; San Martín-López JV
    Clin Immunol; 2020 Sep; 218():108518. PubMed ID: 32599278
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!
    Lazzerini PE; Boutjdir M; Capecchi PL
    Circulation; 2020 Jul; 142(1):7-9. PubMed ID: 32286863
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of COVID-19 pandemic on lung cancer treatment scheduling.
    Fujita K; Ito T; Saito Z; Kanai O; Nakatani K; Mio T
    Thorac Cancer; 2020 Oct; 11(10):2983-2986. PubMed ID: 32790028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing patients with hematological malignancies during COVID-19 pandemic.
    Sahu KK; Cerny J
    Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in lung cancer therapy during the COVID-19 pandemic.
    Calabrò L; Peters S; Soria JC; Di Giacomo AM; Barlesi F; Covre A; Altomonte M; Vegni V; Gridelli C; Reck M; Rizvi N; Maio M
    Lancet Respir Med; 2020 Jun; 8(6):542-544. PubMed ID: 32278368
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Lung Cancer During the COVID-19 Pandemic.
    Singh AP; Berman AT; Marmarelis ME; Haas AR; Feigenberg SJ; Braun J; Ciunci CA; Bauml JM; Cohen RB; Kucharczuk JC; Shulman LN; Langer CJ; Aggarwal C
    JCO Oncol Pract; 2020 Sep; 16(9):579-586. PubMed ID: 32453656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID-19 pandemic on subarachnoid hemorrhage.
    Bernat AL; Giammattei L; Abbritti R; Froelich S
    J Neurosurg Sci; 2020 Aug; 64(4):409-410. PubMed ID: 32347681
    [No Abstract]   [Full Text] [Related]  

  • 17. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 18. Productivity of Young Experts in Hemostasis and Thrombosis before and during the SARS-CoV-2 Pandemic-A Special Issue.
    Scharf RE
    Hamostaseologie; 2020 Aug; 40(3):255-256. PubMed ID: 32726820
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 20. [Not Available].
    Fumeaux T
    Rev Med Suisse; 2020 Apr; 16(690):756. PubMed ID: 32301314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.